Sopharma AD (WSE:SPH)
Poland · Delayed Price · Currency is PLN 12.75
-0.25 (-1.92%)
Dec 9, 2025, 6:19 PM CET
Sopharma AD Market Cap
Sopharma AD has a market cap or net worth of 3.16 billion as of December 10, 2025. Its market cap has increased by 49.57% in one year.
Market Cap
3.16B
Enterprise Value
4.52B
Revenue
5.47B
Ranking
n/a
PE Ratio
11.68
Stock Price
12.75
Market Cap Chart
Since April 29, 2008, Sopharma AD's market cap has increased from 1.45B to 3.16B, an increase of 118.08%. That is a compound annual growth rate of 4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 3.15B | 50.53% |
| Dec 27, 2024 | 2.09B | 3.56% |
| Dec 29, 2023 | 2.02B | 55.99% |
| Dec 29, 2022 | 1.29B | -0.80% |
| Dec 30, 2021 | 1.30B | 38.47% |
| Dec 30, 2020 | 942.29M | 1.15% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.85B |
| NEUCA | 3.61B |
| Synektik Spólka Akcyjna | 2.33B |
| Voxel | 1.32B |
| Celon Pharma | 1.13B |
| Selvita | 853.53M |
| Ryvu Therapeutics | 682.04M |
| Centrum Medyczne ENEL-MED | 497.73M |